Pfizer-BioNTech COVID vaccine approved for emergency use in Sri Lanka | Daily News

Pfizer-BioNTech COVID vaccine approved for emergency use in Sri Lanka

The National Medicines Regulatory Authority (NMRA) of Sri Lanka has approved the emergency use of the COVID-19 vaccine ‘Pfizer-BioNTech'. Five million doses of the vaccine will be imported in the near future, said the State Minister Dr. Sudharshini Fernandopulle.

 


Update:

Sri Lanka approves Pfizer-BioNTech COVID vaccine for Emergency Use

Ishara Mudugamuwa

The Advisory Board of the National Medicines Regulatory Authority (NMRA) has authorized the COVID-19 vaccine designed and developed by Pfizer and its partner BioNTech for Emergency Use in Sri Lanka and vaccine rollout is planned to begin soon, State Minister of Primary Health Care, Epidemic and COVID Disease Control Dr. Sudharshani Fernandopulle said yesterday.

Speaking to the media yesterday, the State Minister said that the measures will be taken to import five million doses of Pfizer vaccines in the near future.

The vaccine was shown to be 95 percent effective in neutralizing more contagious variants of the novel coronavirus.

Sri Lanka on Thursday (6) began rolling out the Sputnik V vaccine for COVID-19 developed by the Gamaleya Research Institute of Epidemiology and Microbiology in Russia.

Residents of Gothatuwa between the ages of 30 and 60 were the first to be administered the Sputnik V vaccine. Dr. Fernandopulle said that the first dose of SputnikV vaccines has already been administered to near 661 individuals and no side effects reported so far.